Adial Pharmaceuticals

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$0
$0
$0
$
Gross Profit
EBITDA
-1,793
-1,882
-2,267
-2,070
EBIT
-1,793
-1,882
-2,267
-2,070
Net Income
-1,793
-1,958
-2,228
-2,070
Net Change In Cash
0
0
0
Free Cash Flow
-1,833
-1,749
-1,585
-1,453
Cash
4,606
5,914
2,365
3,750
Basic Shares
22,171
10,622
18,588
18,588

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-60
-55
EBITDA
-8,283
-7,001
-10,858
-17,685
EBIT
-8,284
-7,001
-10,859
-17,740
Net Income
-13,197
-7,001
-12,731
-19,423
Net Change In Cash
0
0
0
0
Free Cash Flow
-6,922
-6,806
-11,185
-12,014
Cash
3,750
2,827
4,001
6,062
Basic Shares
18,588
1,424
1,063
743

Earnings Calls

QuarterEPS
2025-09-30
-$0.08
2025-06-30
-$0.18
2025-03-31
-$0.34
2024-12-31
-$0.15